BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary

BioLife Solutions

06/08/2026 22:12

BioLife Solutions, Inc. BLFS.OQ reported quarterly adjusted earnings of 91 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -1 cents.  The mean expectation of nine analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from 3 cents to 4 cents per share.
Revenue rose 12% to $28.47 million from a year ago; analysts expected $27.68 million. 
BioLife Solutions, Inc.'s reported EPS for the quarter was 91 cents​.
The company reported quarterly net income of $45.1 million.
BioLife Solutions, Inc. shares had risen by 19.7% this quarter and gained 39.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 16.7% in the last three months.​ 
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 7 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."
Wall Street's median 12-month price target for BioLife Solutions, Inc. is $31.00, about 9% below its last closing price of $33.80
This summary was machine generated from LSEG data August 6 at 09:12 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.03
0.91
Beat
Mar. 31 2026 
0.02
0.02
Met
Dec. 31 2025 
-0.02
0.22
Beat
Sep. 30 2025 
-0.01
0.01
Beat